These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10908120)

  • 41. Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics.
    Barsby T; Kelly MT; Gagné SM; Andersen RJ
    Org Lett; 2001 Feb; 3(3):437-40. PubMed ID: 11428033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
    Palombo EA; Semple SJ
    J Basic Microbiol; 2002; 42(6):444-8. PubMed ID: 12442307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.
    Hoellman DB; Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4037-9. PubMed ID: 15388474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiologic characteristics of resistant microorganisms present in reserves from an intensive care unit.
    de Oliveira AC; Damasceno QS; Piscoya M; Nicoli JR
    Am J Infect Control; 2012 Mar; 40(2):186-7. PubMed ID: 21824685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.
    Socha AM; Garcia D; Sheffer R; Rowley DC
    J Nat Prod; 2006 Jul; 69(7):1070-3. PubMed ID: 16872146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibacterial activities of temporin A analogs.
    Wade D; Silberring J; Soliymani R; Heikkinen S; Kilpeläinen I; Lankinen H; Kuusela P
    FEBS Lett; 2000 Aug; 479(1-2):6-9. PubMed ID: 10940378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
    Parhi AK; Zhang Y; Saionz KW; Pradhan P; Kaul M; Trivedi K; Pilch DS; LaVoie EJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4968-74. PubMed ID: 23891185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
    Socha AM; Laplante KL; Russell DJ; Rowley DC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
    Bergeret M; Raymond J
    J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antibacterial activities of 2-oxaisocephems.
    Tsubouchi H; Tsuji K; Yasumura K; Ishikawa H
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2084-9. PubMed ID: 7805133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
    Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
    Raymond J; Vedel G; Bergeret M
    J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
    Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA; Singh KV; Panesso D; Murray BE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1996; 42(6):432-8. PubMed ID: 8957577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.